IMV Inc.
IMV Inc. IMV.TO Peers
See (IMV.TO) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IMV.TO | $1.12 | N/A | 13.12M | -0.18 | -$6.11 | N/A |
| BLU.TO | $19.48 | -0.10% | 2.47B | -20.29 | -$0.96 | N/A |
| MMED.NE | $14.90 | +9.48% | 1.05B | -4.50 | -$3.31 | N/A |
| DRUG.CN | $44.47 | -1.68% | 313.25M | -222.35 | -$0.20 | N/A |
| FRX.TO | $11.34 | +19.37% | 313.20M | -378.00 | -$0.03 | N/A |
| CYBN.NE | $9.75 | +3.94% | 205.01M | -1.97 | -$4.96 | N/A |
| EPRX.TO | $5.36 | +0.19% | 192.15M | -5.06 | -$1.06 | N/A |
| MSCL.TO | $0.66 | +4.76% | 101.23M | 2.64 | $0.25 | N/A |
| MDNA.TO | $1.14 | +0.88% | 89.17M | -3.08 | -$0.37 | N/A |
| GLAB.CN | $1.03 | N/A | 77.11M | -20.60 | -$0.05 | N/A |
Stock Comparison
IMV.TO vs BLU.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, BLU.TO has a market cap of 2.47B. Regarding current trading prices, IMV.TO is priced at $1.12, while BLU.TO trades at $19.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas BLU.TO's P/E ratio is -20.29. In terms of profitability, IMV.TO's ROE is -4.95%, compared to BLU.TO's ROE of -0.22%. Regarding short-term risk, IMV.TO is more volatile compared to BLU.TO. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs MMED.NE Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, MMED.NE has a market cap of 1.05B. Regarding current trading prices, IMV.TO is priced at $1.12, while MMED.NE trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas MMED.NE's P/E ratio is -4.50. In terms of profitability, IMV.TO's ROE is -4.95%, compared to MMED.NE's ROE of -0.33%. Regarding short-term risk, IMV.TO is less volatile compared to MMED.NE. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs DRUG.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, DRUG.CN has a market cap of 313.25M. Regarding current trading prices, IMV.TO is priced at $1.12, while DRUG.CN trades at $44.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas DRUG.CN's P/E ratio is -222.35. In terms of profitability, IMV.TO's ROE is -4.95%, compared to DRUG.CN's ROE of -0.06%. Regarding short-term risk, IMV.TO is more volatile compared to DRUG.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs FRX.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, FRX.TO has a market cap of 313.20M. Regarding current trading prices, IMV.TO is priced at $1.12, while FRX.TO trades at $11.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas FRX.TO's P/E ratio is -378.00. In terms of profitability, IMV.TO's ROE is -4.95%, compared to FRX.TO's ROE of +0.19%. Regarding short-term risk, IMV.TO is less volatile compared to FRX.TO. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs CYBN.NE Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, CYBN.NE has a market cap of 205.01M. Regarding current trading prices, IMV.TO is priced at $1.12, while CYBN.NE trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas CYBN.NE's P/E ratio is -1.97. In terms of profitability, IMV.TO's ROE is -4.95%, compared to CYBN.NE's ROE of -0.39%. Regarding short-term risk, IMV.TO is less volatile compared to CYBN.NE. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs EPRX.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, EPRX.TO has a market cap of 192.15M. Regarding current trading prices, IMV.TO is priced at $1.12, while EPRX.TO trades at $5.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas EPRX.TO's P/E ratio is -5.06. In terms of profitability, IMV.TO's ROE is -4.95%, compared to EPRX.TO's ROE of -1.21%. Regarding short-term risk, IMV.TO is more volatile compared to EPRX.TO. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs MSCL.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, MSCL.TO has a market cap of 101.23M. Regarding current trading prices, IMV.TO is priced at $1.12, while MSCL.TO trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas MSCL.TO's P/E ratio is 2.64. In terms of profitability, IMV.TO's ROE is -4.95%, compared to MSCL.TO's ROE of -0.74%. Regarding short-term risk, IMV.TO is more volatile compared to MSCL.TO. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs MDNA.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, MDNA.TO has a market cap of 89.17M. Regarding current trading prices, IMV.TO is priced at $1.12, while MDNA.TO trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas MDNA.TO's P/E ratio is -3.08. In terms of profitability, IMV.TO's ROE is -4.95%, compared to MDNA.TO's ROE of -1.64%. Regarding short-term risk, IMV.TO is more volatile compared to MDNA.TO. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs GLAB.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, GLAB.CN has a market cap of 77.11M. Regarding current trading prices, IMV.TO is priced at $1.12, while GLAB.CN trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas GLAB.CN's P/E ratio is -20.60. In terms of profitability, IMV.TO's ROE is -4.95%, compared to GLAB.CN's ROE of +1.38%. Regarding short-term risk, IMV.TO is more volatile compared to GLAB.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs MSET.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, MSET.CN has a market cap of 74.96M. Regarding current trading prices, IMV.TO is priced at $1.12, while MSET.CN trades at $0.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas MSET.CN's P/E ratio is -12.33. In terms of profitability, IMV.TO's ROE is -4.95%, compared to MSET.CN's ROE of -3.17%. Regarding short-term risk, Volatility data is not available for a full comparison. IMV.TO has daily volatility of 5.45 and MSET.CN has daily volatility of N/A.
IMV.TO vs SVA.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, SVA.TO has a market cap of 68.98M. Regarding current trading prices, IMV.TO is priced at $1.12, while SVA.TO trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas SVA.TO's P/E ratio is -2.33. In terms of profitability, IMV.TO's ROE is -4.95%, compared to SVA.TO's ROE of +2.30%. Regarding short-term risk, IMV.TO is more volatile compared to SVA.TO. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs ONCO.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, ONCO.CN has a market cap of 62.89M. Regarding current trading prices, IMV.TO is priced at $1.12, while ONCO.CN trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas ONCO.CN's P/E ratio is -145.00. In terms of profitability, IMV.TO's ROE is -4.95%, compared to ONCO.CN's ROE of -3.52%. Regarding short-term risk, IMV.TO is less volatile compared to ONCO.CN. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs ONC.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, ONC.TO has a market cap of 51.85M. Regarding current trading prices, IMV.TO is priced at $1.12, while ONC.TO trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas ONC.TO's P/E ratio is -1.46. In terms of profitability, IMV.TO's ROE is -4.95%, compared to ONC.TO's ROE of -2.25%. Regarding short-term risk, IMV.TO is less volatile compared to ONC.TO. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs PMN.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, PMN.TO has a market cap of 51.48M. Regarding current trading prices, IMV.TO is priced at $1.12, while PMN.TO trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas PMN.TO's P/E ratio is -1.78. In terms of profitability, IMV.TO's ROE is -4.95%, compared to PMN.TO's ROE of -5.57%. Regarding short-term risk, IMV.TO is less volatile compared to PMN.TO. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs HBP.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, HBP.TO has a market cap of 50.37M. Regarding current trading prices, IMV.TO is priced at $1.12, while HBP.TO trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas HBP.TO's P/E ratio is -0.90. In terms of profitability, IMV.TO's ROE is -4.95%, compared to HBP.TO's ROE of +21.43%. Regarding short-term risk, IMV.TO is more volatile compared to HBP.TO. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs DTC.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, DTC.CN has a market cap of 49.80M. Regarding current trading prices, IMV.TO is priced at $1.12, while DTC.CN trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas DTC.CN's P/E ratio is -10.11. In terms of profitability, IMV.TO's ROE is -4.95%, compared to DTC.CN's ROE of +1.22%. Regarding short-term risk, IMV.TO is more volatile compared to DTC.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs MBX.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, MBX.TO has a market cap of 47.87M. Regarding current trading prices, IMV.TO is priced at $1.12, while MBX.TO trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas MBX.TO's P/E ratio is 34.00. In terms of profitability, IMV.TO's ROE is -4.95%, compared to MBX.TO's ROE of +0.07%. Regarding short-term risk, IMV.TO is more volatile compared to MBX.TO. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs IGX.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, IGX.TO has a market cap of 41.92M. Regarding current trading prices, IMV.TO is priced at $1.12, while IGX.TO trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas IGX.TO's P/E ratio is -3.00. In terms of profitability, IMV.TO's ROE is -4.95%, compared to IGX.TO's ROE of +0.93%. Regarding short-term risk, IMV.TO is less volatile compared to IGX.TO. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs DOSE.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, DOSE.CN has a market cap of 30.18M. Regarding current trading prices, IMV.TO is priced at $1.12, while DOSE.CN trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas DOSE.CN's P/E ratio is -5.87. In terms of profitability, IMV.TO's ROE is -4.95%, compared to DOSE.CN's ROE of +1.61%. Regarding short-term risk, IMV.TO is less volatile compared to DOSE.CN. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs BCT.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, BCT.TO has a market cap of 28.29M. Regarding current trading prices, IMV.TO is priced at $1.12, while BCT.TO trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas BCT.TO's P/E ratio is -0.75. In terms of profitability, IMV.TO's ROE is -4.95%, compared to BCT.TO's ROE of +66.06%. Regarding short-term risk, IMV.TO is less volatile compared to BCT.TO. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs AEZS.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, AEZS.TO has a market cap of 25.38M. Regarding current trading prices, IMV.TO is priced at $1.12, while AEZS.TO trades at $8.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas AEZS.TO's P/E ratio is -2.61. In terms of profitability, IMV.TO's ROE is -4.95%, compared to AEZS.TO's ROE of -0.67%. Regarding short-term risk, IMV.TO is less volatile compared to AEZS.TO. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs PHRM.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, PHRM.CN has a market cap of 20.80M. Regarding current trading prices, IMV.TO is priced at $1.12, while PHRM.CN trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas PHRM.CN's P/E ratio is -4.70. In terms of profitability, IMV.TO's ROE is -4.95%, compared to PHRM.CN's ROE of -0.83%. Regarding short-term risk, IMV.TO is less volatile compared to PHRM.CN. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs REUN.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, REUN.TO has a market cap of 16.64M. Regarding current trading prices, IMV.TO is priced at $1.12, while REUN.TO trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas REUN.TO's P/E ratio is -0.43. In terms of profitability, IMV.TO's ROE is -4.95%, compared to REUN.TO's ROE of -1.10%. Regarding short-term risk, IMV.TO is more volatile compared to REUN.TO. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs PREV.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, PREV.CN has a market cap of 16.25M. Regarding current trading prices, IMV.TO is priced at $1.12, while PREV.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas PREV.CN's P/E ratio is -30.00. In terms of profitability, IMV.TO's ROE is -4.95%, compared to PREV.CN's ROE of +0.19%. Regarding short-term risk, IMV.TO is more volatile compared to PREV.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs TELI.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, TELI.CN has a market cap of 14.77M. Regarding current trading prices, IMV.TO is priced at $1.12, while TELI.CN trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas TELI.CN's P/E ratio is -9.17. In terms of profitability, IMV.TO's ROE is -4.95%, compared to TELI.CN's ROE of -2.08%. Regarding short-term risk, IMV.TO is more volatile compared to TELI.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs BETR.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, BETR.CN has a market cap of 14.25M. Regarding current trading prices, IMV.TO is priced at $1.12, while BETR.CN trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas BETR.CN's P/E ratio is -3.67. In terms of profitability, IMV.TO's ROE is -4.95%, compared to BETR.CN's ROE of +0.43%. Regarding short-term risk, IMV.TO is more volatile compared to BETR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs MDMA.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, MDMA.CN has a market cap of 12.73M. Regarding current trading prices, IMV.TO is priced at $1.12, while MDMA.CN trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas MDMA.CN's P/E ratio is -6.75. In terms of profitability, IMV.TO's ROE is -4.95%, compared to MDMA.CN's ROE of -0.86%. Regarding short-term risk, IMV.TO is less volatile compared to MDMA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs BIOV.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, BIOV.CN has a market cap of 11.66M. Regarding current trading prices, IMV.TO is priced at $1.12, while BIOV.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas BIOV.CN's P/E ratio is -2.00. In terms of profitability, IMV.TO's ROE is -4.95%, compared to BIOV.CN's ROE of +4.49%. Regarding short-term risk, IMV.TO is less volatile compared to BIOV.CN. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs RVX.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, RVX.TO has a market cap of 11.34M. Regarding current trading prices, IMV.TO is priced at $1.12, while RVX.TO trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas RVX.TO's P/E ratio is -1.00. In terms of profitability, IMV.TO's ROE is -4.95%, compared to RVX.TO's ROE of +0.06%. Regarding short-term risk, IMV.TO is less volatile compared to RVX.TO. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs GLOW.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, GLOW.CN has a market cap of 11.22M. Regarding current trading prices, IMV.TO is priced at $1.12, while GLOW.CN trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas GLOW.CN's P/E ratio is -1.83. In terms of profitability, IMV.TO's ROE is -4.95%, compared to GLOW.CN's ROE of +12.80%. Regarding short-term risk, IMV.TO is less volatile compared to GLOW.CN. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs TBP.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, TBP.TO has a market cap of 10.58M. Regarding current trading prices, IMV.TO is priced at $1.12, while TBP.TO trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas TBP.TO's P/E ratio is -0.31. In terms of profitability, IMV.TO's ROE is -4.95%, compared to TBP.TO's ROE of -4.68%. Regarding short-term risk, IMV.TO is more volatile compared to TBP.TO. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs BLAB.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, BLAB.CN has a market cap of 10.55M. Regarding current trading prices, IMV.TO is priced at $1.12, while BLAB.CN trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas BLAB.CN's P/E ratio is -1.30. In terms of profitability, IMV.TO's ROE is -4.95%, compared to BLAB.CN's ROE of -4.53%. Regarding short-term risk, IMV.TO is more volatile compared to BLAB.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs MCUR.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, MCUR.CN has a market cap of 7.04M. Regarding current trading prices, IMV.TO is priced at $1.12, while MCUR.CN trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas MCUR.CN's P/E ratio is -0.75. In terms of profitability, IMV.TO's ROE is -4.95%, compared to MCUR.CN's ROE of -1.61%. Regarding short-term risk, IMV.TO is more volatile compared to MCUR.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs COOL.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, COOL.CN has a market cap of 6.83M. Regarding current trading prices, IMV.TO is priced at $1.12, while COOL.CN trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas COOL.CN's P/E ratio is -1.32. In terms of profitability, IMV.TO's ROE is -4.95%, compared to COOL.CN's ROE of -2.90%. Regarding short-term risk, IMV.TO is more volatile compared to COOL.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs APS.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, APS.TO has a market cap of 6.05M. Regarding current trading prices, IMV.TO is priced at $1.12, while APS.TO trades at $2.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas APS.TO's P/E ratio is -0.10. In terms of profitability, IMV.TO's ROE is -4.95%, compared to APS.TO's ROE of +3.67%. Regarding short-term risk, IMV.TO is more volatile compared to APS.TO. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs TRYP.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, TRYP.CN has a market cap of 5.79M. Regarding current trading prices, IMV.TO is priced at $1.12, while TRYP.CN trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas TRYP.CN's P/E ratio is -1.50. In terms of profitability, IMV.TO's ROE is -4.95%, compared to TRYP.CN's ROE of +1.31%. Regarding short-term risk, IMV.TO is more volatile compared to TRYP.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs ASEP.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, ASEP.CN has a market cap of 5.56M. Regarding current trading prices, IMV.TO is priced at $1.12, while ASEP.CN trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas ASEP.CN's P/E ratio is -0.83. In terms of profitability, IMV.TO's ROE is -4.95%, compared to ASEP.CN's ROE of -0.40%. Regarding short-term risk, IMV.TO is more volatile compared to ASEP.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs CMND.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, CMND.CN has a market cap of 5.07M. Regarding current trading prices, IMV.TO is priced at $1.12, while CMND.CN trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas CMND.CN's P/E ratio is -0.04. In terms of profitability, IMV.TO's ROE is -4.95%, compared to CMND.CN's ROE of -0.46%. Regarding short-term risk, IMV.TO is more volatile compared to CMND.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs GTTX.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, GTTX.CN has a market cap of 4.65M. Regarding current trading prices, IMV.TO is priced at $1.12, while GTTX.CN trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas GTTX.CN's P/E ratio is -12.00. In terms of profitability, IMV.TO's ROE is -4.95%, compared to GTTX.CN's ROE of -0.60%. Regarding short-term risk, IMV.TO is more volatile compared to GTTX.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs AWKN.NE Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, AWKN.NE has a market cap of 3.86M. Regarding current trading prices, IMV.TO is priced at $1.12, while AWKN.NE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas AWKN.NE's P/E ratio is -0.36. In terms of profitability, IMV.TO's ROE is -4.95%, compared to AWKN.NE's ROE of +2.31%. Regarding short-term risk, IMV.TO is more volatile compared to AWKN.NE. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs MYND.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, MYND.CN has a market cap of 3.35M. Regarding current trading prices, IMV.TO is priced at $1.12, while MYND.CN trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas MYND.CN's P/E ratio is -3.50. In terms of profitability, IMV.TO's ROE is -4.95%, compared to MYND.CN's ROE of +0.18%. Regarding short-term risk, IMV.TO is less volatile compared to MYND.CN. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs IPCI.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, IPCI.TO has a market cap of 2.65M. Regarding current trading prices, IMV.TO is priced at $1.12, while IPCI.TO trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas IPCI.TO's P/E ratio is -0.67. In terms of profitability, IMV.TO's ROE is -4.95%, compared to IPCI.TO's ROE of +0.16%. Regarding short-term risk, IMV.TO is less volatile compared to IPCI.TO. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs AGN.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, AGN.CN has a market cap of 2.44M. Regarding current trading prices, IMV.TO is priced at $1.12, while AGN.CN trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas AGN.CN's P/E ratio is 2.83. In terms of profitability, IMV.TO's ROE is -4.95%, compared to AGN.CN's ROE of +0.15%. Regarding short-term risk, IMV.TO is less volatile compared to AGN.CN. This indicates potentially lower risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs APLI.TO Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, APLI.TO has a market cap of 2.43M. Regarding current trading prices, IMV.TO is priced at $1.12, while APLI.TO trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas APLI.TO's P/E ratio is -0.67. In terms of profitability, IMV.TO's ROE is -4.95%, compared to APLI.TO's ROE of +0.32%. Regarding short-term risk, IMV.TO is more volatile compared to APLI.TO. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs ENBI.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, ENBI.CN has a market cap of 1.52M. Regarding current trading prices, IMV.TO is priced at $1.12, while ENBI.CN trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas ENBI.CN's P/E ratio is -2.75. In terms of profitability, IMV.TO's ROE is -4.95%, compared to ENBI.CN's ROE of -1.33%. Regarding short-term risk, IMV.TO is more volatile compared to ENBI.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs MOOD.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, MOOD.CN has a market cap of 1.49M. Regarding current trading prices, IMV.TO is priced at $1.12, while MOOD.CN trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas MOOD.CN's P/E ratio is -5.50. In terms of profitability, IMV.TO's ROE is -4.95%, compared to MOOD.CN's ROE of -0.28%. Regarding short-term risk, IMV.TO is more volatile compared to MOOD.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs BRAX.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, BRAX.CN has a market cap of 1.42M. Regarding current trading prices, IMV.TO is priced at $1.12, while BRAX.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas BRAX.CN's P/E ratio is -0.10. In terms of profitability, IMV.TO's ROE is -4.95%, compared to BRAX.CN's ROE of -2.49%. Regarding short-term risk, IMV.TO is more volatile compared to BRAX.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs HAVN.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, HAVN.CN has a market cap of 1.15M. Regarding current trading prices, IMV.TO is priced at $1.12, while HAVN.CN trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas HAVN.CN's P/E ratio is -0.01. In terms of profitability, IMV.TO's ROE is -4.95%, compared to HAVN.CN's ROE of +0.00%. Regarding short-term risk, IMV.TO is more volatile compared to HAVN.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs LEXT.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, LEXT.CN has a market cap of 1.03M. Regarding current trading prices, IMV.TO is priced at $1.12, while LEXT.CN trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas LEXT.CN's P/E ratio is -0.40. In terms of profitability, IMV.TO's ROE is -4.95%, compared to LEXT.CN's ROE of -2.39%. Regarding short-term risk, IMV.TO is more volatile compared to LEXT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs CHGX.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, CHGX.CN has a market cap of 415648.00. Regarding current trading prices, IMV.TO is priced at $1.12, while CHGX.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas CHGX.CN's P/E ratio is -0.50. In terms of profitability, IMV.TO's ROE is -4.95%, compared to CHGX.CN's ROE of +0.23%. Regarding short-term risk, IMV.TO is more volatile compared to CHGX.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs NSHS.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, NSHS.CN has a market cap of 411008.00. Regarding current trading prices, IMV.TO is priced at $1.12, while NSHS.CN trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas NSHS.CN's P/E ratio is 1.00. In terms of profitability, IMV.TO's ROE is -4.95%, compared to NSHS.CN's ROE of +0.09%. Regarding short-term risk, IMV.TO is more volatile compared to NSHS.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs CURE.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, CURE.CN has a market cap of 408018.00. Regarding current trading prices, IMV.TO is priced at $1.12, while CURE.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas CURE.CN's P/E ratio is 0.17. In terms of profitability, IMV.TO's ROE is -4.95%, compared to CURE.CN's ROE of -2.58%. Regarding short-term risk, IMV.TO is more volatile compared to CURE.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs ABRT.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, ABRT.CN has a market cap of 372067.00. Regarding current trading prices, IMV.TO is priced at $1.12, while ABRT.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas ABRT.CN's P/E ratio is -0.10. In terms of profitability, IMV.TO's ROE is -4.95%, compared to ABRT.CN's ROE of +16.27%. Regarding short-term risk, IMV.TO is more volatile compared to ABRT.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs WBIO.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, WBIO.CN has a market cap of 324764.00. Regarding current trading prices, IMV.TO is priced at $1.12, while WBIO.CN trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas WBIO.CN's P/E ratio is 0.41. In terms of profitability, IMV.TO's ROE is -4.95%, compared to WBIO.CN's ROE of +0.01%. Regarding short-term risk, IMV.TO is more volatile compared to WBIO.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs NIRV.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, NIRV.CN has a market cap of 289398.00. Regarding current trading prices, IMV.TO is priced at $1.12, while NIRV.CN trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas NIRV.CN's P/E ratio is -0.30. In terms of profitability, IMV.TO's ROE is -4.95%, compared to NIRV.CN's ROE of +0.00%. Regarding short-term risk, IMV.TO is more volatile compared to NIRV.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.
IMV.TO vs NOVA.CN Comparison
IMV.TO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IMV.TO stands at 13.12M. In comparison, NOVA.CN has a market cap of 148319.00. Regarding current trading prices, IMV.TO is priced at $1.12, while NOVA.CN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IMV.TO currently has a P/E ratio of -0.18, whereas NOVA.CN's P/E ratio is -0.05. In terms of profitability, IMV.TO's ROE is -4.95%, compared to NOVA.CN's ROE of -0.02%. Regarding short-term risk, IMV.TO is more volatile compared to NOVA.CN. This indicates potentially higher risk in terms of short-term price fluctuations for IMV.TO.